50
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Genome sequencing has become a powerful tool for studying emerging infectious diseases; however, genome sequencing directly from clinical samples without isolation remains challenging for viruses such as Zika, where metagenomic sequencing methods may generate insufficient numbers of viral reads. Here we present a protocol for generating coding-sequence complete genomes comprising an online primer design tool, a novel multiplex PCR enrichment protocol, optimised library preparation methods for the portable MinION sequencer (Oxford Nanopore Technologies) and the Illumina range of instruments, and a bioinformatics pipeline for generating consensus sequences. The MinION protocol does not require an internet connection for analysis, making it suitable for field applications with limited connectivity. Our method relies on multiplex PCR for targeted enrichment of viral genomes from samples containing as few as 50 genome copies per reaction. Viral consensus sequences can be achieved starting with clinical samples in 1-2 days following a simple laboratory workflow. This method has been successfully used by several groups studying Zika virus evolution and is facilitating an understanding of the spread of the virus in the Americas.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          Performance comparison of benchtop high-throughput sequencing platforms.

          Three benchtop high-throughput sequencing instruments are now available. The 454 GS Junior (Roche), MiSeq (Illumina) and Ion Torrent PGM (Life Technologies) are laser-printer sized and offer modest set-up and running costs. Each instrument can generate data required for a draft bacterial genome sequence in days, making them attractive for identifying and characterizing pathogens in the clinical setting. We compared the performance of these instruments by sequencing an isolate of Escherichia coli O104:H4, which caused an outbreak of food poisoning in Germany in 2011. The MiSeq had the highest throughput per run (1.6 Gb/run, 60 Mb/h) and lowest error rates. The 454 GS Junior generated the longest reads (up to 600 bases) and most contiguous assemblies but had the lowest throughput (70 Mb/run, 9 Mb/h). Run in 100-bp mode, the Ion Torrent PGM had the highest throughput (80–100 Mb/h). Unlike the MiSeq, the Ion Torrent PGM and 454 GS Junior both produced homopolymer-associated indel errors (1.5 and 0.38 errors per 100 bases, respectively).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Target-enrichment strategies for next-generation sequencing.

            We have not yet reached a point at which routine sequencing of large numbers of whole eukaryotic genomes is feasible, and so it is often necessary to select genomic regions of interest and to enrich these regions before sequencing. There are several enrichment approaches, each with unique advantages and disadvantages. Here we describe our experiences with the leading target-enrichment technologies, the optimizations that we have performed and typical results that can be obtained using each. We also provide detailed protocols for each technology so that end users can find the best compromise between sensitivity, specificity and uniformity for their particular project.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The evolution of Ebola virus: Insights from the 2013-2016 epidemic.

              The 2013-2016 epidemic of Ebola virus disease in West Africa was of unprecedented magnitude and changed our perspective on this lethal but sporadically emerging virus. This outbreak also marked the beginning of large-scale real-time molecular epidemiology. Here, we show how evolutionary analyses of Ebola virus genome sequences provided key insights into virus origins, evolution and spread during the epidemic. We provide basic scientists, epidemiologists, medical practitioners and other outbreak responders with an enhanced understanding of the utility and limitations of pathogen genomic sequencing. This will be crucially important in our attempts to track and control future infectious disease outbreaks.
                Bookmark

                Author and article information

                Journal
                101284307
                33047
                Nat Protoc
                Nat Protoc
                Nature protocols
                1754-2189
                1750-2799
                3 April 2018
                24 May 2017
                June 2017
                16 April 2018
                : 12
                : 6
                : 1261-1276
                Affiliations
                [1 ]Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, UK
                [2 ]The Scripps Research Institute, La Jolla, CA, USA
                [3 ]Public Health England, National infection Service, Porton Down, Salisbury, UK
                [4 ]Department of Infectious Disease and Institute of Tropical Medicine, University of Saõ Paulo, Saõ Paulo, Brazil
                [5 ]Scripps Translational Science Institute, La Jolla, CA, USA
                [6 ]Massachusetts General Hospital, Boston, USA
                [7 ]Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro
                [8 ]Fiocruz Bahia, Salvador, Brazil
                [9 ]University of Rome, Tor Vergata
                [10 ]Department of Zoology, University of Oxford, Oxford, UK
                [11 ]Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, USA
                [12 ]Department of Epidemiology, University of Washington, Seattle, USA
                [13 ]University of Southampton, South General Hospital, Southampton, UK
                [14 ]Instituto Evandro Chagas, Belem, Brazil
                [15 ]Paul-Ehrlich-Institut, Langen, Germany
                [16 ]University of Nottingham, Nottingham, UK
                [17 ]OICR, Toronto, Canada
                Author notes
                Correspondence should be addressed to N.J.L ( n.j.loman@ 123456bham.ac.uk )
                Article
                PMC5902022 PMC5902022 5902022 nihpa956343
                10.1038/nprot.2017.066
                5902022
                28538739
                d2586534-3cbe-45b6-aa7e-92ec5db943e5
                History
                Categories
                Article

                Comments

                Comment on this article